Packaged intervention targeting oral antimicrobials in Japanese tertiary care outpatient setting: a quasi-experimental study
JAC-Antimicrobial Resistance · 02.07.2026 · 8 (4)
DOI: 10.1093/jacamr/dlag133 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 07.07.2026. Verfasst von Hiroshi Horiuchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Institute of Science Tokyo, Graduate School of Medical and Dental Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To evaluate an outpatient, antimicrobial stewardship intervention targeting broad-spectrum antimicrobials including third-generation cephalosporins, fluoroquinolones, and macrolides, during an antimicrobial shortage at a Japanese, tertiary hospital.
Methods
This before-and-after interventional study was conducted at a tertiary hospital. The intervention included department-focused and hospital-wide education, local guidelines, weekly post-prescription review and feedback, monthly reports on days of therapy (DOT), a formulary review, and an orientation for newly transferred physicians. Counterfactual monthly outcomes (primary endpoint: DOT per 100 visits (DOT/100V) and number of prescriptions per 1000 visits (Rx/1000V) for the target antimicrobials) were predicted on the basis of pre-intervention data using ordinary least squares regression incorporating oral antimicrobial shortages.
Results
The post-intervention use of third-generation cephalosporins decreased (DOT/100 V mean difference [MD]: −0.87; 95% confidence interval [CI]: −0.97 to −0.76; Rx/1000 V MD: −3.85; 95% CI: −4.06 to −3.65) together with that of fluoroquinolones (DOT/100V: −1.92; 95% CI: −2.33 to −1.51; Rx/1000V MD: −2.14; 95% CI: −2.60 to −1.68). The volume and frequency of macrolide use did not differ significantly, but inappropriate prescriptions of fluoroquinolones (−26.22%) and macrolides (−7.92%) decreased.
Conclusions
This outpatient stewardship programme evaluated within a counterfactual framework accounted for supply shortages, reduced third-generation cephalosporins and fluoroquinolone use, and improved the appropriateness of prescriptions. Sustaining these gains requires on-going evidence-based data-sharing and prescriber-tailored interventions.
Autor:innen und Institutionen
- Department of Infectious Diseases, Institute of Science Tokyo, Graduate School of Medical and Dental Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
- Department of Infection Control, National Hospital Organization, Yokohama Medical Center, Kanagawa, Japan.
- Center for Infectious Disease Education and Analysis, Institute of Science Tokyo (TCIDEA), Tokyo, Japan.
- Department of Biostatistics, M&D Data Science Center, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.
ORCID-Profile: Hiroshi Horiuchi, Yasuaki Tagashira, Yoshiaki Gu
Zitieren
APA
Horiuchi, H., Tagashira, Y., Takizawa, A., Takahashi, K., & Gu, Y. (2026). Packaged intervention targeting oral antimicrobials in Japanese tertiary care outpatient setting: a quasi-experimental study. JAC-Antimicrobial Resistance, 8(4). https://doi.org/10.1093/jacamr/dlag133
Vancouver
Horiuchi H, Tagashira Y, Takizawa A, Takahashi K, Gu Y. Packaged intervention targeting oral antimicrobials in Japanese tertiary care outpatient setting: a quasi-experimental study. JAC-Antimicrobial Resistance. 2026;8(4). doi:10.1093/jacamr/dlag133
BibTeX
@article{Horiuchi2026,
author = {Horiuchi, Hiroshi and Tagashira, Yasuaki and Takizawa, Asami and Takahashi, Kunihiko and Gu, Yoshiaki},
title = {Packaged intervention targeting oral antimicrobials in Japanese tertiary care outpatient setting: a quasi-experimental study},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {4},
doi = {10.1093/jacamr/dlag133}
}
EUVIMED